Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burroughs

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trialLauri M Burroughs, Eneida R Nemecek, Troy R Torgerson, et al.
Transplantation and Cellular Therapy|March 15, 2022
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy ConsortiumHemalatha G Rangarajan, Joseph R Stanek, Hisham Abdel-Azim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2017
Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid LeukemiaH Joachim Deeg, Emily A Stevens, Rachel B Salit, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2025
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriersShanmuganathan Chandrakasan, Adrianna Westbrook, Linda M Griffith, et al.
Blood Advances|April 12, 2023
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCTAshley V Geerlinks, Brooks Scull, Christa Krupski, et al.
Blood Advances|June 20, 2025
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide studyChristo Tsilifis, Johannes Raedler, Joanna Renke, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Blood|April 9, 2020
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC reportLauri M Burroughs, Aleksandra Petrovic, Ruta Brazauskas, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trialLauri M Burroughs, Eneida R Nemecek, Troy R Torgerson, et al.
Transplantation and Cellular Therapy|March 15, 2022
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy ConsortiumHemalatha G Rangarajan, Joseph R Stanek, Hisham Abdel-Azim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2017
Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid LeukemiaH Joachim Deeg, Emily A Stevens, Rachel B Salit, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2025
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriersShanmuganathan Chandrakasan, Adrianna Westbrook, Linda M Griffith, et al.
Blood Advances|April 12, 2023
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCTAshley V Geerlinks, Brooks Scull, Christa Krupski, et al.
Blood Advances|June 20, 2025
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide studyChristo Tsilifis, Johannes Raedler, Joanna Renke, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Blood|April 9, 2020
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC reportLauri M Burroughs, Aleksandra Petrovic, Ruta Brazauskas, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Pageof 9